Searched for
STRIDES PHARMA STOCK
Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facilityStrides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...- INDO-MIM, Ather Energy and TCS among stocks bought and sold by mutual funds in JulyMutual funds bought Rs 15,900 crore of stocks in July while FIIs sold Rs 11,000 crore. Axis Bank, INDO-MIM and Kotak Mahindra Bank saw majo...
- Bonus issues & dividends: Wipro, UltraTech Cement among more than 110 stocks turning ex-date this week. Do you own?Over 110 companies, including Wipro, UltraTech Cement and Britannia, will turn ex-date this week for dividends and bonus issues. Investors ...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- Stock Radar: Strides Pharma stock hits fresh 52-week high in July; will the rally continue in August?Strides Pharma Science Limited stock shows positive momentum. It broke a one-month consolidation in July 2025. Experts suggest a buy for a ...
- Stock Radar: Strides Pharma breaks out from 7-month consolidation to hit fresh 52-week high; time to buy?Strides Pharma Science stock shows positive movement. It broke a seven-month consolidation phase. Experts suggest a buy with a target of Rs...
- Stock Radar: This pharma stock gave multibagger returns in the last 1 year; should you buy, sell or hold Strides Pharma?Strides Pharma Science Ltd (STAR) surged over 200% in a year, hitting Rs 1,675 in October. After a dip, the stock rebounded from its 20-wee...
- Stock Radar: This pharma stock sees mild consolidation after 130% rally in 1 year; time to buy the dip?The pharma stock is a part of the S&P BSE Smallcap index. It saw an uptrend, rising from Rs 393 as of June 9, 2023, to Rs 901 recorded on J...
- Buy Strides Pharma Science, target price Rs 630: Prabhudas LilladherPromoters held 28.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.72 per cent, DIIs 19.59 per cent.
- Reduce Strides Pharma Science, target price Rs 495: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 4766.18 Crore) operating in Pha...
- Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businessesAs per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. T...
- Strides Pharma announces business rejig. Shares end 7% up, hit 52 week highThe announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday's...
- Smallcap pharma stock jumps over 11% as arm receives tentative USFDA approval for HIV drug DolutegravirThe company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of whic...
- Buy Strides Pharma Science, target price Rs 500: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3085.64 Crore) operating in Pha...
- Buy Strides Pharma Science, target price Rs 402: ICICI SecuritiesStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3026.83 Crore) operating in Pha...
- Accumulate Strides Pharma Science, target price Rs 355: GeojitStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2836.92 Crore) operating in Pha...
- Strides Pharma Science Q3 net declines 69% to Rs 92 croreThe consolidated income of the company increased to Rs 744.66 crore in the Oct-Dec period.
- Buy pharma stocks on declines: P Phani Sekhar, Angel BrokingThings have been good for some midcap pharma companies. Although they remained midcap in their classification but revenues have almost star...
- Sun Pharma, Cipla best bet among pharma stocks: Sajiv DhawanMost of the times these stocks will trade in a range. It is not a sector that I say would outperform even in the next year or so.
Load More
